Clinical Trials Browser

Completed × Lenalidomide × Gastrointestinal × Clear all

NCT01352962 2026-01-05

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Phase 1 Completed

GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT07184424 2025-09-19

Lenalidomide

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT01547260 2022-08-22

LENAGEM

Phase 1/2 Completed

Gastrointestinal

Pancreatic Carcinoma Metastatic

NCT00717756 2020-02-17

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Phase 2 Completed

41 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

NCT01545804 2017-02-09

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase 1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00837031 2013-03-13

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms